Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

Citation

  • Authors: Rota IA. et al.
  • Year: 2021
  • Journal: Sci Adv 7 eabj9247
  • Applications: in vitro / DNA / PEIpro
  • Cell type: HEK-293T
    Description: Human embryonic kidney Fibroblast
    Known as: HEK293T, 293T

Method

- For the production of infectious lentivirus, 1.2×10^7 HEK-293T cells were plated onto a 15-cm tissue culture dish. - Twenty-four hours after plating, cells were cotransfected with the lentiviral transfer vector (EYFP5tFOXN1CMV) and the psPAX2 and pMD2.G viral packaging vectors at a ratio of 4:3:2 using PEIpro (PolyPlus Transfection) following the manufacturer’s protocol. - Culture medium was exchanged 6 hours after transfection with 10 ml of fresh DMEM complemented with 10% FBS, NEAA, penicillinstreptomycin, and l-glutamine. - The lentiviral supernatant was collected at 48 and 72 hours after transfection, pooled and filtered with a 0.45-um cellulose acetate syringe filter, and subsequently overlaid onto 5 ml of 20% sucrose and ultracentrifuged at 24,000 rpm for 2.5 hours. The viral pellet was resuspended in PBS.

Abstract

The transcription factor FOXN1 is a master regulator of thymic epithelial cell (TEC) development and function. Here, we demonstrate that FOXN1 expression is differentially regulated during organogenesis and participates in multimolecular nuclear condensates essential for the factor’s transcriptional activity. FOXN1’s C-terminal sequence regulates the diffusion velocity within these aggregates and modulates the binding to proximal gene regulatory regions. These dynamics are altered in a patient with a mutant FOXN1 that is modified in its C-terminal sequence. This mutant is transcriptionally inactive and acts as a dominant negative factor displacing wild-type FOXN1 from condensates and causing athymia and severe lymphopenia in heterozygotes. Expression of the mutated mouse ortholog selectively impairs mouse TEC differentiation, revealing a gene dose dependency for individual TEC subtypes. We have therefore identified the cause for a primary immunodeficiency disease and determined the mechanism by which this FOXN1 gain-of-function mutant mediates its dominant negative effect.

Go to